Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Neutral 63.5%

Neg 0% Neu 63.5% Pos 0%

Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $6 to $9.